Antinuclear antibody screening in this new millennium: Farewell to the microscope?

Scandinavian Journal of Rheumatology

Volumn 30, Issue 3, 2001, Pages 123-126

  Nossent, Hans ^a   Rekvig, Ole Petter ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Antinuclear antibodies; ELISA; Immunofluorescence; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CELL ANTIGEN; CELL NUCLEUS ANTIGEN;

ANTIBODY DETECTION; ANTIBODY SCREENING; AUTOIMMUNE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LABORATORY DIAGNOSIS; MICROSCOPY; PREDICTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; STANDARDIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035000905     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097401300162860     Document Type: Review

References (20)

1. Hargraves MM. Presentation of two bone marrow elements: the 'tart' cell and the 'LE' cell. Mayo Clin Proc 1948; 23:25-8.
2. Schett G, Rubin RL, Steiner G, Hiesberger H, Muller S, Smolen J. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera. Arthritis Rheum 2000;43:420-8.
3. Tan EM. The LE cell and its legacy. Clin Exp Rheumatol 1998;16:652-8.
4. Friou CJ. Clinical application of lupus serum nucleoprotein reaction using immunofluorescent antibody technique. J Clin Invest 1957;36:890-7.
5. Tan EM. Antinuclear antibodies: diagnostic markers and clues to the basis of systemic autoimmunity. Pediatr Infect Dis J 1988;7 Suppl 5:S3-9.
6. Feldman BM, Reichlin M, Laxer RM, Targoff IN, Stein LD, Silverman ED. Clinical significance of specific autoantibodies in juvenile dermatomyositis. J Rheumatol 1996; 23:1794-7
7. Clough JD, Calabrese LH, Valenzuela R. The ANA profile: quality and cost-effective laboratory utilization. Clev Clin J Med 1989;56:245-8.
8. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71-8.
9. Guidelines for the referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus. Arthritis Rheum 1999;42:1785-96.
10. Uhlig T, Kvien T, Glennås A, Smedstad LM, Førre Ø. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 1998; 25:1078-84.
11. Nossent JC. Systemic Lupus Erythematosus in the Arctic region of Norway. J Rheumatol 2001 (in press).
12. Slater CA, Davis RB, Schmerling RH. Antinuclear antibody testing. Arch Intern Med 1996; 156:1421-5.
13. Reichlin, M. ANA negative systemic lupus erythematosus sera revisited serologically. Lupus 2000;9:116-9.
14. Solomon DH, Schmerling RH, Schur PH, Lew R, Fiskio J, Bates DW. A computer based intervention to reduce unnecessary serologic testing. J Rheumatol 1999;26:2578-84.
15. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in 'healthy' individuals. Arthritis Rheum 1997;40:1601-11.
16. Tan EM, Smolen JS, McDougal JS, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum 1999;42:455-64.
17. Olaussen E, Rekvig OP. Screening tests for antinuclear antibodies (ANA): selective use of central nuclear antigens as a rational basis for screening by ELISA. J Autoimmun 1999;13:95-102.
18. Rubin RL. Etiology and mechanisms of drug-induced lupus. Curr Opin Rheumatol 1999; 11:357-63.
19. Tomer SY. Aging and autoantibodies. Autoimmunity 1988;1:141-9.
20. Schoenfeld Y, Cohen IR.. Infections and autoimmunity. In:Sela M, ed. The antigens. Vol. VII. San Diego:Academic Press, 1987:317-29.